0001192482-19-000034.txt : 20190123
0001192482-19-000034.hdr.sgml : 20190123
20190123160639
ACCESSION NUMBER: 0001192482-19-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190118
FILED AS OF DATE: 20190123
DATE AS OF CHANGE: 20190123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celano Michael
CENTRAL INDEX KEY: 0001377582
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 19537485
MAIL ADDRESS:
STREET 1: 220 EAST FIRST STREET
CITY: BETHLEHEM
STATE: PA
ZIP: 18015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-01-18
0001588972
Recro Pharma, Inc.
REPH
0001377582
Celano Michael
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
0
1
0
0
Chief Operating Officer
Common Stock
2019-01-18
4
A
0
12672
0
A
39445
D
Common Stock
2019-01-18
4
M
0
6400
A
45845
D
Common Stock
2019-01-18
4
F
0
1782
7.99
D
44063
D
Employee Stock Option (right to buy)
7.99
2019-01-18
4
A
0
60592
0
A
2029-01-18
Common Stock
60592
60592
D
Restricted Stock Units
2019-01-18
4
M
0
6400
0
D
Common Stock
6400
12800
D
All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
Restricted stock units convert into common stock on a one-for-one basis.
Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units..
The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.
On January 18, 2017, the reporting person was granted 25,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
/s/ Ryan D. Lake, as attorney-in-fact
2019-01-22